Personas / Equipo Humano

Héctor Salvador Hernández

Buscador de publicaciones

Publicaciones

  • Bao R, Ng A, Sasaki M, Esai Selvan M, Katti A, Lee H, Huang L, Skol AD, Lavarino C, Salvador-Hernandez H, Klein RJ, Gümüs ZH, Mora J and Onel K.

    Functional Common and Rare ERBB2 Germline Variants Cooperate in Familial and Sporadic Cancer Susceptibility

    CANCER PREVENTION RESEARCH . 14(4): 441-453. Nº de citas: 2

    [doi:10.1158/1940-6207.CAPR-20-0094]

  • Cruz-Martínez O, Caloretti V, Salvador-Hernandez H, Celis-Passini V, Santa-María López V, Morales-La Madrid A, Suñol M, Puerta P, Muchart-Lopez J, Krauel L and Lavarino C.

    Synchronous choroid plexus papilloma and Wilms tumor in a girl, disclosing a Li-Fraumeni syndrome

    HEREDITARY CANCER IN CLINICAL PRACTICE . 19(1): 1-1.

    [doi:10.1186/s13053-020-00158-7]

  • Dávila Osorio VL, Vicente-Villa MA, Baselga E, Salvador-Hernandez H, Cruz-Martínez O and Prat-Torres CS.

    Adverse cutaneous effects of mitogen-activated protein kinase inhibitors in children

    PEDIATRIC DERMATOLOGY . 38(2): 420-423. Nº de citas: 1

    [doi:10.1111/pde.14354]

  • Fernández-Rodríguez J, Morales-La Madrid A, Gel B, Castañeda-Heredia A, Salvador-Hernandez H, Martínez-Iniesta M, Moutinho C, Morata J, Heyn H, Blanco I, Creus-Bachiller E, Capella G, Farré L, Vidal A, Soldado F, Krauel L, Suñol M, Serra E, Villanueva A and Lázaro C.

    Use of patient derived orthotopic xenograft models for real-time therapy guidance in a pediatric sporadic malignant peripheral nerve sheath tumor

    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY . 12: . Nº de citas: 5

    [doi:10.1177/1758835920929579]

  • Pinto EM, Figueiredo BC, Chen W, Galvao HCR, Formiga MN, Fragoso MCBV, Ashton-Prolla P, Ribeiro EMSF, Felix G, Costa TEB, Savage SA, Yeager M, Palmero EI, Volc S, Salvador-Hernandez H, Fuster-Soler JL, Lavarino C, Chantada G, Vaur D, Odone-Filho V, Brugières L, Else T, Stoffel EM, Maxwell KN, Achatz MI, Kowalski L, de Andrade KC, Pappo A, Letouze E, Latronico AC, Mendonca BB, Almeida MQ, Brondani VB, Bittar CM, Soares EWS, Mathias C, Ramos CRN, Machado M, Zhou W, Jones K, Vogt A, Klincha PP, Santiago KM, Komechen H, Paraizo MM, Parise IZS, Hamilton KV, Wang J, Rampersaud E, Clay MR, Murphy AJ, Lalli E, Nichols KE, Ribeiro RC, Rodriguez-Galindo C, Korbonits M, Zhang J, Thomas MG, Connelly JP, Pruett-Miller S, Diekmann Y, Neale G, Wu G and Zambetti GP.

    XAF1 as a modifier of p53 function and cancer susceptibility.

    Science Advances . 6(26): . Nº de citas: 33

    [doi:10.1126/sciadv.aba3231]

  • Renzi S, Michaeli O, Salvador-Hernandez H, Alderete D, Ponce NF, Zapotocky M, Hansford JR, Malalasekera VS, Toledano H, Maguire B, Bouffet E, Ramaswamy V and Baroni LV.

    Bevacizumab for NF2-associated vestibular schwannomas of childhood and adolescence.

    PEDIATRIC BLOOD & CANCER . 67(5): . Nº de citas: 14

    [doi:10.1002/pbc.28228]

  • González-Acosta M, Marín F, Puliafito B, Bonifaci N, Fernández A, Navarro M, Salvador-Hernandez H, Balaguer F, Iglesias S, Velasco A, Grau Garces E, Moreno V, Gonzalez-Granado LI, Guerra-García P, Ayala R, Florkin B, Kratz C, Ripperger T, Rosenbaum T, Januszkiewicz-Lewandowska D, Azizi AA, Ragab I, Nathrath M, Pander HJ, Lobitz S, Suerink M, Dahan K, Imschweiler T, Demirsoy U, Brunet J, Lázaro C, Rueda D, Wimmer K, Capellá G and Pineda M.

    High-sensitivity microsatellite instability assessment for the detection of mismatch repair defects in normal tissue of biallelic germline mismatch repair mutation carriers

    JOURNAL OF MEDICAL GENETICS . 57(4): 269-273. Nº de citas: 17

    [doi:10.1136/jmedgenet-2019-106272]

  • Castellanos E, Rosas I, Negro A, Gel B, Alibés A, Baena N, Pineda M, Pi G, Pintos G, Salvador-Hernandez H, Lazaro C, Blanco I, Vilageliu L, Brems H, Grinberg-Vaisman DR, Legius E and Serra E.

    Mutational spectrum by phenotype: panel-based NGS testing of patients with clinical suspicion of RASopathy and children with multiple café-au-lait macules.

    CLINICAL GENETICS . 97(2): 264-275. Nº de citas: 14

    [doi:10.1111/cge.13649]

  • D'Angelo F, Ceccarelli M, Tala, Garofano L, Zhang J, Frattini V, Caruso FP, Lewis G, Alfaro KD, Bauchet L, Berzero G, Cachia D, Cangiano M, Capelle L, de Groot J, DiMeco F, Ducray F, Farah W, Finocchiaro G, Goutagny S, Kamiya-Matsuoka C, Lavarino C, Loiseau H, Lorgis V, Marras CE, McCutcheon I, Nam DH, Ronchi S, Saletti V, Seizeur R, Slopis J, Suñol M, Vandenbos F, Varlet P, Vidaud D, Watts C, Tabar V, Reuss DE, Kim SK, Meyronet D, Mokhtari K, Salvador-Hernandez H, Bhat KP, Eoli M, Sanson M, Lasorella A and Iavarone A.

    The molecular landscape of glioma in patients with Neurofibromatosis 1

    NATURE MEDICINE . 25(1): 176-187. Nº de citas: 128

    [doi:10.1038/s41591-018-0263-8]

  • Castellanos E, Plana A, Carrato C, Carrio M, Rosas I, Amilibia E, Roca-Ribas F, Hostalot C, Castillo A, Ros A, Quer A, Becerra JL, Salvador-Hernandez H, Lazaro C, Blanco I, Serra E, Bielsa I and for CSUR Phakomatoses Multidisciplinary Clinics HUGTiP-ICO-IGTP.

    Early Genetic Diagnosis of Neurofibromatosis Type 2 From Skin Plaque Plexiform Schwannomas in Childhood.

    JAMA DERMATOLOGY . 154(3): 341-346. Nº de citas: 8

    [doi:10.1001/jamadermatol.2017.5464]